Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on rifampicin resistant and multidrug resistant tuberculosis in India and China.
WEERASURIYA, C; Harris, R; MCQUAID, C; BOZZANI, F; Gomez, GB; WHITE, R;
2020
(2020).
Do evaluations of Tuberculosis Active Case Finding report estimates of resource need? A review of the evidence.
Clarkson, MC; MCQUAID, CF; HOUBEN, RM; Menzies, N; SWEENEY, S; KRANZER, K; WHITE, RG;
2020
(2020).
Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda.
KITONSA, J; Ggayi, A-B; ANYWAINE, Z; Kisaakye, E; Nsangi, L; Basajja, V; NYANTARO, M; WATSON-JONES, D; Shukarev, G; Ilsbroux, I; Robinson, C; KALEEBU, P;
2020
GLOBAL HEALTH ACTION, (2020).13 1 10.1080/16549716.2020.1829829.
Parents' and guardians' views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England.
BELL, S; Clarke, R; MOUNIER-JACK, S; WALKER, JL; PATERSON, P;
2020
Vaccine, (2020).38 49 10.1016/j.vaccine.2020.10.027.
Assessment of missed opportunities for vaccination (MOV) in Burkina Faso using the World Health Organization's revised MOV strategy: Findings and strategic considerations to improve routine childhood immunization coverage.
Kaboré, L; Meda, B; Médah, I; Shendale, S; Nic Lochlainn, L; SANDERSON, C; Ouattara, M; Kaboré, WM F; Betsem, E; Ogbuanu, IU;
2020
VACCINE, (2020).38 48 10.1016/j.vaccine.2020.10.021.
Informing Global Cost-Effectiveness Thresholds Using Country Investment Decisions: Human Papillomavirus Vaccine Introductions in 2006-2018.
JIT, M;
2020
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, (2020).24 1 10.1016/j.jval.2020.07.012.
The determinants of vaccine hesitancy in China: A cross-sectional study following the Changchun Changsheng vaccine incident.
Du, F; CHANTLER, T; Francis, MR; SUN, FY; Zhang, X; HAN, K; Rodewald, L; Yu, H; Tu, S; LARSON, H; Hou, Z;
2020
Vaccine, (2020).38 47 10.1016/j.vaccine.2020.09.075.
Potential impact of tuberculosis vaccines in China, South Africa, and India.
Harris, RC; SUMNER, T; KNIGHT, GM; Zhang, H; WHITE, RG;
2020
Science Translational Medicine, (2020).12 564 10.1126/scitranslmed.aax4607.
Keeping track of the SARS-CoV-2 vaccine pipeline.
PARKER, EP K; Shrotri, M; KAMPMANN, B;
2020
NATURE REVIEWS IMMUNOLOGY, (2020).20 11 10.1038/s41577-020-00455-1.
Immune responses to malaria pre-erythrocytic stages: Implications for vaccine development.
Abuga, KM; JONES-WARNER, W; HAFALLA, JC R;
2020
Parasite Immunology, (2020).43 2 10.1111/pim.12795.